We're Leaders in
World Class Medical Research
You can help
July 10, 2016 – The Cooley’s Anemia Foundation is accepting applications from individuals with thalassemia for the 2016 CAF ApoPharma Distinguished Scholar Award. The CAF-ApoPharma Distinguished Scholar Award, which was established in 2014, is made possible through a grant from pharmaceutical manufacturer ApoPharma.
CAF will award up to two scholarships to a U.S. citizen(s) with a clinically significant form of thalassemia pursuing doctoral studies in biomedical sciences, including medicine, pharmacy, nursing and basic research. (Ph.D., M.D., D.D.S., Pharm.D., D.V.M, etc.) in the United States or abroad. Total annual funding available for the awards is $20,000. Students enrolled in a doctoral program for the fall of 2016 are eligible to apply.
A clinically significant form of thalassemia would include alpha thalassemia major, beta thalassemia major, beta thalassemia intermedia, e beta thalassemia, hemoglobin H disease, or hemoglobin H disease-Constant Spring.
In awarding the funds for this scholarship project in 2014, Dr. Michael Spino, President of ApoPharma, noted that “over the past decade, we have been impressed by several thalassemia patients who are making notable contributions to society, based on their innate capabilities. In some cases, we believe that their contributions would be augmented if they had an opportunity to pursue postgraduate education. Indeed, we know several who have gone on to complete graduate education, who then became role models for other thalassemia patients. Yet, the ability of some thalassemia patients to pursue a postgraduate education may be limited due to financial constraints.”
Dr. Spino added, “We are excited about this opportunity and think it could serve as an inspiration to thalassemia patients throughout the U.S.”
Applications must be received at CAF by September 30, 2016. The application form can be downloaded by clicking here.
In addition, all applicants must be registered with the Cooley’s Anemia Foundation. (Applicants who are unsure if they are registered with the Foundation should contact CAF Patient Services Manager Eileen Scott at email@example.com).
Patients can apply via email or regular mail. Email applications should be sent to firstname.lastname@example.org with the subject line “Distinguished Scholarship Application.” Those sending in applications via regular mail should address them to:
Scholarship Review Committee
Cooley’s Anemia Foundation
330 Seventh Avenue, Suite 200
New York, NY 10001
All applications will be reviewed by a diverse panel which may request additional information from applicants.